EFFECTS OF KLIGMAN-WILLIS’S TRIPLE COMBINATION THERAPY ON QUALITY OF LIFE IN FEMALE MELASMA PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TAHERI RAMIN; ASADI SALMAN; GHORBANI NARGES; GHORBANI RAHEB

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Koomesh Year:2016 | Volume:18 | Issue:1 (61) Page(s): 220-226

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

6,991

Download:

Cites:

Information Journal Paper

Title

EFFECTS OF KLIGMAN-WILLIS’S TRIPLE COMBINATION THERAPY ON QUALITY OF LIFE IN FEMALE MELASMA PATIENTS

Author(s)

TAHERI RAMIN | ASADI SALMAN | GHORBANI NARGES | GHORBANI RAHEB | Issue Writer Certificate

Keywords

MELANOSISQ1

QUALITY OF LIFEQ2

HYDROQUINONESQ1

TRETINOINQ3

DEXAMETHASONEQ3

DRUG COMBINATIONSQ1

Abstract

Introduction: Melasma is common cause of skin hyperpigmentation. It’s characterized by symmetric, irregular light brown to dark brown patches of hyperMELANOSIS on parts of the body with most exposure to sun light. Melasma has a significant adverse impact on patients' QUALITY OF LIFE (QoL). The aim of this study was to evaluate the effect of Kligman-Willis’s formula treatment in female with melasma on their QoL.Materials and Methods: In this study, 21 female patients, 15 or higher years old, referred to Semnan University of Medical Sciences (Semnan, Iran) dermatology clinicduring 2013, were enrolled in the study. They were recognized with melasma for the first time. Treatment of patients with Kligman-Willis formula which contains 5% hydroquinone, TRETINOIN 0.1% and DEXAMETHASONE 0.1%, was done. This formula is a hydrophilic ointment base and is used topically. Treatment was continued for three months and the patients were instructed to apply the medication on the site of the lesion every night. QUALITY OF LIFE before and after 3 month treatment with Kligman-Willis’s formula was investigated by DLQI (Dermatology Life Quality Index) questionnaire.Results: Mean ±SD age of the patients was 28.3±7.2 years. Level of educational in 76.2% (n=16) of patients was diploma or lower. 85.7% (n=18) of patients were married. 85.7% of patients had lesion on the face. Before treatment, in 52.4 % of patients the skin disease had very large effect and in 47.6% of patients had extreme effect on QoL. Mean± SD score of DLQI before treatment was 20.29±4.55 and after 3 months treatment decrease to 14.10±3.94, that was statistically significant (p<0.001).Conclusion: Findings showed that, treatment of melasma patients with Kligman-Willis formula based on a three-month period, would improve the QUALITY OF LIFE of patients.

Cites

No record.

References

Cite

Related Journal Papers